Published OCT 7, 2026

Virginia Home Health & Home Care Franchise, Established 2012

Virginia

$1.2M
SDE
4.3x
Multiple
Subscribe Free

Read the full deal writeup

Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a home care and home health business operating under an established national franchise brand in an affluent, fast-growing Virginia metro. It delivers a full continuum of care spanning both non-medical and medical lines: personal care, companion care, skilled general nursing, infusion and pediatric skilled care, plus medical and non-medical staffing for skilled and personal care patients. Founded in 2012, it carries real brand recognition, mature referral networks, and proven clinical and operational systems that come with the franchise system.

The positioning is the part worth noting. The company serves a market where over 16% of residents are 65+ with household incomes and home values well above national averages, which supports a private-pay model with standardized pricing, limited discounting, and crucially a complete absence of Medicaid exposure. That reimbursement profile is the difference between healthy, controllable margins and the reimbursement grind that hobbles so many home health operators. On $1.2M of EBITDA at a $5.2M ask, you are paying 4.33x for a diversified, private-pay-heavy book in a demographic that is only getting older and wealthier.

The seller is retiring and the business operates out of roughly 7,684 square feet of leased office across multiple suites, so this is a clean going-concern sale with no real estate to inflate the multiple. Service-line diversification across skilled and non-skilled, plus explicit runway into Medicare and national accounts, gives a buyer multiple levers without needing to reinvent the model.

Why we like it

  • At 4.33x for $1.2M EBITDA, you are buying a 13-year-old operating business with proven profitability, not a startup promise. The private-pay orientation and standardized pricing mean these earnings are not propped up by a single fragile reimbursement stream, which makes the EBITDA more believable than a typical home health comp.
  • The complete absence of Medicaid exposure is the single most durable feature here. Most home health operators live and die by reimbursement rate changes and slow government payment cycles, and this business has sidestepped that entirely by serving an affluent private-pay population, which protects margins and cash conversion.
  • Demographics are doing the heavy lifting. A local metro with 16%+ of residents aged 65 and up, above-average incomes, and an aging national baby boomer wave means demand for in-home care compounds for the next two decades regardless of the economic cycle.
  • The franchise brand delivers name recognition, referral networks, and ready-made clinical and operational systems, so an operator buyer inherits infrastructure rather than building it. Combined with diversified skilled and non-skilled service lines, this reduces single-point-of-failure risk and gives multiple cross-sell paths into the same patient base.
  • This is genuinely recession-resistant and recurring by nature. Patients needing personal care, skilled nursing, and pediatric or infusion care do not stop needing it when the market turns, and care relationships recur by default week after week rather than requiring each sale to be re-won.

How to improve it

  • Launch a Medicare certification and billing capability. The listing explicitly flags Medicare and skilled Medicaid cases as untapped runway, and adding a controlled, high-acuity payer channel diversifies revenue without abandoning the lucrative private-pay core.
  • Deepen referral pipelines with major hospital systems and national accounts in the first 90 days. The brand already has partnerships and media visibility, so formalizing preferred-provider agreements and referral SLAs can lift volume and improve payer mix quickly.
  • Build a dedicated caregiver recruiting and retention engine. The listing names workforce expansion as the gating factor for volume growth, so an applicant-tracking funnel, referral bonuses, and retention programs directly convert into billable hours and revenue.
  • Introduce premium concierge-style care tiers for the affluent base. Given above-average incomes and willingness to pay, a higher-margin concierge offering captures more dollars per existing client without proportionally increasing acquisition cost.
  • Expand higher-acuity skilled nursing and infusion services where demand is rising. These command better rates than companion care, so shifting mix toward skilled work raises revenue per visit and strengthens the clinical moat against lower-skill competitors.
  • Tighten scheduling and utilization with better workforce-management software. Home care margins live in filled shifts and minimized drive time, so optimizing caregiver utilization directly expands EBITDA from the existing client base.
  • Formalize community education and outreach into a measurable organic-referral program. The business already has media visibility and community trust, so systematizing outreach events and tracking referral attribution turns goodwill into a predictable lead channel.

Diligence notes

  • Demand the full revenue figure and payer-mix breakdown immediately, since gross revenue is not disclosed. You need to confirm the private-pay versus any skilled/insurance split and verify the claimed absence of Medicaid exposure, because the entire margin thesis rests on it.
  • Scrutinize caregiver staffing: turnover rates, open-shift and unfilled-visit percentages, W-2 versus 1099 classification, and dependence on any contract staffing. Labor supply is the real constraint in this business and misclassification carries retroactive liability risk.
  • Verify the franchise agreement terms: royalty and ad-fund percentages, remaining term, transfer and renewal conditions, territory protections, and any franchisor consent required for the sale. These fees sit directly against the $1.2M EBITDA and can reduce buyer economics.
  • Assess customer and referral concentration. Confirm no single hospital system, facility, or handful of patients drives an outsized share of revenue, and review the office lease (roughly 7,684 square feet) for remaining term and renewal options since the facility is leased, not owned.
  • Confirm clinical licensure, accreditation, and compliance status, including any state survey history, complaints, or deficiencies. Home health operates under licensing and clinical oversight, and any open compliance issues can impair valuation or delay close.
  • Probe owner dependence despite the retirement framing. Identify whether referral relationships, clinical oversight, and key staff loyalty attach to the owner personally, and structure training, a non-compete, and possibly an earnout to bridge the transition risk.

Source

Originally listed on BizBuySell. View original listing →

Want the full analysis on every deal? Unlock the complete platform with Accredited Pro to screen live listings and read our operator-level writeups.